lapatinib has been researched along with vincaleukoblastine in 3 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (vincaleukoblastine) | Trials (vincaleukoblastine) | Recent Studies (post-2010) (vincaleukoblastine) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 69 | 0 | 64 |
| Protein | Taxonomy | lapatinib (IC50) | vincaleukoblastine (IC50) |
|---|---|---|---|
| Tubulin beta-4A chain | Homo sapiens (human) | 0.74 | |
| Tubulin beta chain | Homo sapiens (human) | 0.74 | |
| Tubulin alpha-3C chain | Homo sapiens (human) | 0.74 | |
| Proteasome subunit beta type-1 | Homo sapiens (human) | 4.28 | |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 8.8 | |
| Proteasome subunit beta type-5 | Homo sapiens (human) | 4.58 | |
| Proteasome subunit beta type-2 | Homo sapiens (human) | 4.9 | |
| Tubulin alpha-1B chain | Homo sapiens (human) | 0.74 | |
| Tubulin alpha-4A chain | Homo sapiens (human) | 0.74 | |
| Tubulin beta-4B chain | Homo sapiens (human) | 0.74 | |
| Tubulin beta-3 chain | Homo sapiens (human) | 0.74 | |
| Tubulin beta-2A chain | Homo sapiens (human) | 0.74 | |
| Tubulin beta-8 chain | Homo sapiens (human) | 0.74 | |
| Tubulin alpha-3E chain | Homo sapiens (human) | 0.74 | |
| Tubulin alpha-1A chain | Homo sapiens (human) | 0.74 | |
| Tubulin alpha-1C chain | Homo sapiens (human) | 0.74 | |
| Tubulin beta-6 chain | Homo sapiens (human) | 0.74 | |
| Tubulin beta-2B chain | Homo sapiens (human) | 0.74 | |
| Tubulin beta-1 chain | Homo sapiens (human) | 0.74 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Afratis, K; Gavras, H; Karamanos, NK; Koutsakis, C; Leonardi, S; Papaioannou, D; Piperigkou, Z; Rassias, G; Rigopoulou, D; Vachlioti, E | 1 |
1 review(s) available for lapatinib and vincaleukoblastine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for lapatinib and vincaleukoblastine
| Article | Year |
|---|---|
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Potent antiproliferative activity of bradykinin B2 receptor selective agonist FR-190997 and analogue structures thereof: A paradox resolved?
Topics: Anti-Bacterial Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; MCF-7 Cells; Quinolines; Receptor, Bradykinin B2 | 2021 |